DK1433480T3 - Lægemiddel indeholdende pyrimidin-derivat - Google Patents

Lægemiddel indeholdende pyrimidin-derivat

Info

Publication number
DK1433480T3
DK1433480T3 DK02745972.6T DK02745972T DK1433480T3 DK 1433480 T3 DK1433480 T3 DK 1433480T3 DK 02745972 T DK02745972 T DK 02745972T DK 1433480 T3 DK1433480 T3 DK 1433480T3
Authority
DK
Denmark
Prior art keywords
drug containing
pyrimidine derivative
containing pyrimidine
carbon atom
alkyl group
Prior art date
Application number
DK02745972.6T
Other languages
English (en)
Inventor
Tomiichiro Oda
Shigeko Uryu
Shinya Tokuhiro
Original Assignee
Btg Internat Ltd Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Btg Internat Ltd Company filed Critical Btg Internat Ltd Company
Application granted granted Critical
Publication of DK1433480T3 publication Critical patent/DK1433480T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02745972.6T 2001-07-13 2002-07-11 Lægemiddel indeholdende pyrimidin-derivat DK1433480T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001213338 2001-07-13
PCT/JP2002/007060 WO2003006024A1 (en) 2001-07-13 2002-07-11 Medicine containing pyrimidine derivative

Publications (1)

Publication Number Publication Date
DK1433480T3 true DK1433480T3 (da) 2011-04-11

Family

ID=19048332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02745972.6T DK1433480T3 (da) 2001-07-13 2002-07-11 Lægemiddel indeholdende pyrimidin-derivat

Country Status (10)

Country Link
US (2) US7425559B2 (da)
EP (1) EP1433480B1 (da)
JP (1) JP4398724B2 (da)
AT (1) ATE493988T1 (da)
AU (1) AU2002318802B2 (da)
CA (1) CA2457720C (da)
DE (1) DE60238847D1 (da)
DK (1) DK1433480T3 (da)
ES (1) ES2358888T3 (da)
WO (1) WO2003006024A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1433480T3 (da) * 2001-07-13 2011-04-11 Btg Internat Ltd Company Lægemiddel indeholdende pyrimidin-derivat
GB0917774D0 (en) * 2009-10-09 2009-11-25 Senexis Ltd Novel pharmaceutical compounds
GB0917775D0 (en) 2009-10-09 2009-11-25 Btg Int Ltd Novel pharmaceutical compounds

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51141896A (en) 1975-05-31 1976-12-07 Sankyo Co Ltd Process for preparing fused ring triazoropyrimidine derivatives
JPS58437B2 (ja) * 1976-03-26 1983-01-06 三共株式会社 縮環トリアゾロピリミジン誘導体
JPS5353698A (en) 1976-10-20 1978-05-16 Sankyo Co Ltd Pyrrolotriazolopyrimidine derivatives and their preparation
JPS5353697A (en) 1976-10-20 1978-05-16 Sankyo Co Ltd Tricyclic triazolopyrimidine derivatives
JPS5368800A (en) 1976-11-30 1978-06-19 Sankyo Co Ltd Cycloalkyl substd. pyrrolotriazolopyrimidine derivatives
JPS5649391A (en) 1979-09-28 1981-05-02 Mochida Pharmaceut Co Ltd Novel bis- 8h-pyrrolo- 3,2-e -s-triazolo- 1,5-a - pyrimidinomethyl amine derivative
JPS5649385A (en) 1979-09-29 1981-05-02 Mochida Pharmaceut Co Ltd Novel s-triazolo- 1,5-a -pyrimidine derivative
JPS5735593A (en) 1980-08-12 1982-02-26 Mochida Pharmaceut Co Ltd Novel pyrolo 3,2-e -s-triazolo 1,5-a pyrimidine derivative
EP0101517B1 (en) 1982-02-19 1986-10-29 Mochida Pharmaceutical Co., Ltd. Novel s-triazole(1,5-a)pyrimidine derivatives
JPH0276880A (ja) * 1988-06-16 1990-03-16 Sankyo Co Ltd 悪液質改善治療剤
CA1330079C (en) 1988-10-13 1994-06-07 Michihiko Tsujitani Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
JP3898296B2 (ja) 1996-08-28 2007-03-28 ポーラ化成工業株式会社 ピロロピラゾロピリミジン化合物及びこれを有効成分とする医薬
JPH10218881A (ja) 1997-02-03 1998-08-18 Pola Chem Ind Inc 新規なピロロピラゾロピリミジン誘導体
US6245769B1 (en) * 1997-09-02 2001-06-12 Dupont Pharmaceuticals Company Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders
EP0945442A1 (en) 1998-03-27 1999-09-29 Janssen Pharmaceutica N.V. Trisubstituted pyrimidine derivatives
EA002973B1 (ru) 1998-03-27 2002-12-26 Янссен Фармацевтика Н.В. Производные пиримидина в качестве ингибиторов репликации вируса иммунодефицита человека
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents
TWI271406B (en) 1999-12-13 2007-01-21 Eisai Co Ltd Tricyclic condensed heterocyclic compounds, preparation method of the same and pharmaceuticals comprising the same
SE0101523L (sv) 2000-12-29 2002-06-30 Artimplant Ab Linjär polymer
US6693125B2 (en) 2001-01-24 2004-02-17 Combinatorx Incorporated Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
FR2826011B1 (fr) 2001-06-14 2004-12-10 Oreal Nouveaux derives de la 7-oxo-dhea et utilisation cosmetique
DK1433480T3 (da) * 2001-07-13 2011-04-11 Btg Internat Ltd Company Lægemiddel indeholdende pyrimidin-derivat

Also Published As

Publication number Publication date
AU2002318802A1 (en) 2003-01-29
JPWO2003006024A1 (ja) 2004-10-28
DE60238847D1 (de) 2011-02-17
AU2002318802B2 (en) 2007-08-23
CA2457720A1 (en) 2003-01-23
EP1433480A4 (en) 2005-10-05
US20040242605A1 (en) 2004-12-02
CA2457720C (en) 2010-11-02
ES2358888T3 (es) 2011-05-16
EP1433480B1 (en) 2011-01-05
US20090005402A1 (en) 2009-01-01
EP1433480A1 (en) 2004-06-30
US7425559B2 (en) 2008-09-16
ATE493988T1 (de) 2011-01-15
JP4398724B2 (ja) 2010-01-13
US8288399B2 (en) 2012-10-16
WO2003006024A1 (en) 2003-01-23

Similar Documents

Publication Publication Date Title
PT976748E (pt) Derivados de pirrolidina com actividade inibidora de fosfolipase a2
ATE388958T1 (de) 4'-c-substituierte 2-haloadenosinderivate
MXPA06001274A (es) Compuestos novedosos que poseen actividad inhibitoria contra transporador dependiente de sodio.
DE69840296D1 (de) Phenylethylenamin-derivate
ATE358484T1 (de) Antidiabetische medikamente
DE60032016D1 (de) Zyklische aminverbindungen als ccr5-rezeptor antagonisten
DE60223904D1 (de) Benzylaminanalogen
DE60237637D1 (de) Thiadiazolinderivate zur Krebsbehandlung
AU2001269540A1 (en) Serotonin reuptake inhibitors
ATE223411T1 (de) 1-methylcarbapenem-derivate
DE60016384D1 (de) Chondrogonese promotoren und indolin-2-on derivate
DK1433480T3 (da) Lægemiddel indeholdende pyrimidin-derivat
EA200200682A1 (ru) Новые соединения n-бензилпиперазина, способ их получения и фармацевтические композиции, их содержащие
EA200602065A1 (ru) Радиосенсибилизатор
NO20053997L (no) Oligosaccharidderivat
AU2003248059A1 (en) NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
DE60325172D1 (de) Verbindungen als semaphorininhibitoren
EP1325913A3 (en) Piperidinecarboxylic acid amide derivatives